Lise M - Search Results

1

[Complementary treatment to surgery of gastric carcinoma: role of adjuvant and neoadjuvant chemotherapy].

Lise M, Nitti D, Marchet A, Tripodi M, Pilati P, Pasetto L. Lise M, et al. Chir Ital. 1997;49(3):35-9. Chir Ital. 1997. PMID: 9612650 Italian.

2

Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Lise M, Nitti D, Marchet A, Sahmoud T, Duez N, Fornasiero A, dos Santos JG, Labianca R, Lasser P, Gignoux M. Lise M, et al. Ann Surg Oncol. 1995 Nov;2(6):495-501. doi: 10.1007/BF02307082. Ann Surg Oncol. 1995. PMID: 8591079 Clinical Trial.

3

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

Nitti D, Wils J, Dos Santos JG, Fountzilas G, Conte PF, Sava C, Tres A, Coombes RC, Crivellari D, Marchet A, Sanchez E, Bliss JM, Homewood J, Couvreur ML, Hall E, Baron B, Woods E, Emson M, Van Cutsem E, Lise M; EORTC GI Group; ICCG. Nitti D, et al. Among authors: lise m. Ann Oncol. 2006 Feb;17(2):262-9. doi: 10.1093/annonc/mdj077. Epub 2005 Nov 17. Ann Oncol. 2006. PMID: 16293676 Free article.

4

Adjuvant treatment for gastric cancer.

Lise M, Nitti D, Marchet A, Fornasiero A. Lise M, et al. Anticancer Drugs. 1991 Oct;2(5):433-45. doi: 10.1097/00001813-199110000-00001. Anticancer Drugs. 1991. PMID: 1804385 Review.

5

[Controllable gastric banding as an alternative to vertical gastroplasty in the treatment of obesity].

Favretti F, Segato G, Zavagno G, Marchet A, Nitti D, Lise M. Favretti F, et al. Among authors: lise m. G Chir. 1991 Mar;12(3):182-3. G Chir. 1991. PMID: 1873165 Italian. No abstract available.

6

Adjuvant FAM2 in resectable gastric cancer.

Lise M, Nitti D, Buyse M, Marchet A, Fiorentino M, Dos Santos JG, Duez N. Lise M, et al. Anticancer Res. 1989 Jul-Aug;9(4):1017-21. Anticancer Res. 1989. PMID: 2683987 Clinical Trial.

7

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

Lise M, Nitti D, Marchet A, Sahmoud T, Buyse M, Duez N, Fiorentino M, Dos Santos JG, Labianca R, Rougier P, et al. Lise M, et al. J Clin Oncol. 1995 Nov;13(11):2757-63. doi: 10.1200/JCO.1995.13.11.2757. J Clin Oncol. 1995. PMID: 7595735 Clinical Trial.

8

Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.

Rossi CR, Vecchiato A, Foletto M, Nitti D, Ninfo V, Fornasiero A, Sotti G, Tregnaghi A, Melanotte P, Lise M. Rossi CR, et al. Among authors: lise m. Cancer. 1994 Apr 15;73(8):2140-6. doi: 10.1002/1097-0142(19940415)73:8<2140::aid-cncr2820730819>3.0.co;2-0. Cancer. 1994. PMID: 8156518 Clinical Trial.

9

Management of primary sarcomas of the retroperitoneum.

Rossi CR, Nitti D, Foletto M, Alessio S, Seno A, Segato G, Mancino G, De Marchi F, Ninfo V, Lise M. Rossi CR, et al. Among authors: lise m. Eur J Surg Oncol. 1993 Aug;19(4):355-60. Eur J Surg Oncol. 1993. PMID: 8395410

10

Hepatic arterial infusion (HAI) for unresectable liver metastases (ULM) from colorectal carcinoma.

Nitti D, Da Pian P, Pilati P, Bacchetti S, Meneghetti G, Marchet A, Lise M. Nitti D, et al. Among authors: lise m. Tumori. 1997 Jan-Feb;83(1 Suppl):S61. Tumori. 1997. PMID: 9154071 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters